Meyka AI API is live for developers.Start building.
Advertisement
LivaNova PLC

LivaNova PLC (LIVN) Stock Overview

Explore LivaNova PLC’s financial performance, market position, analyst ratings, and future outlook.

LIVNNASDAQ
HealthcareMedical - Devices
$72.36
$1.36(1.84%)
U.S. Market opens in 53h 23m
Advertisement

LivaNova PLC (LIVN)

Meyka AI Score

Z

Key Financials

Market Cap4B
P/E Ratio37.10
EPS (TTM)$1.96
ROE0.09%
Fundamental Analysis

AI Price Forecasts

1 Month$63.05
3 Months$71.02
1 Year Target$57.97

LIVN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of LivaNova PLC (LIVN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 54.10, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $57.97.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 37.10 and a market capitalization of 4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.84%
5-Day Change
-0.56%
1-Month Change
25.65%
3-Month Change
11.84%
6-Month Change
14.20%
Year-to-Date (YTD) Change
17.60%
1-Year Change
61.34%
3-Year Change
56.15%
5-Year Change
-9.65%
All-Time (Max) Change
3.47%

Contact Information

44 20 3325 0660
20 Eastbourne Terrace, London, NaN, W2 6LG

Company Facts

2,900 Employees
IPO DateOct 19, 2015
CountryGB
Actively Trading

Frequently Asked Questions